- The trend backdrop is active with a 5-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
PARKHOSPS
NSI
Week ended 07 Aug 2026
Weekly Investor Report
PARK MEDI WORLD LIMITED · Healthcare · Medical Care Facilities
Latest close
292.2 INR
-0.1%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 26.5% above the Trend Line and sits at 93.6% of its 52-week range. The latest completed week returned -0.1%, after a 2.1% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers. The latest news-sentiment score is 64/100. Near-term considerations: price is close to its 52-week high.
Setup score
57
out of 100
Latest Close
292.2 INR
7 Aug 2026
1W Return
-0.1%
latest completed week
4W Return
2.1%
short-term follow-through
12W Return
19.5%
quarterly tape
Trend Breadth
14.7%
5 of 34 weeks active
Volume Ratio
1.3x
vs 13-week average
- 17 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-0.1%
Latest completed week; four-week move 2.1%.
Indicator stack
25/49
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 65.89%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
64/100
29 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 26.5% above the Trend Line and sits at 93.6% of its 52-week range. The latest completed week returned -0.1%, after a 2.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.8012-week average 0.65
12-week confirmation
Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.80Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers1717 reversal markers
No recent accumulation markers. 17 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 2.1% over four weeks, 19.5% over 12 weeks, and - over one year. The current trend has remained active for 5 consecutive weeks.
Performance by holding period
Active trend streak5 weeks
Active weeks in one year5
Trend breadth14.7%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.31Latest activity-pressure read.
Pressure change-80.3%Four-week change in activity pressure.
Leadership-Latest relative-leadership reading.
RS change-Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 82%
Model confidence 77%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength37/100Blend of value, momentum, and quality. Underlying universe rank 64; rank 1 is best.
Value18/100Relative valuation strength. Underlying universe rank 83; rank 1 is best.
Quality95/100Profitability and accounting quality. Underlying universe rank 6; rank 1 is best.
Momentum50/100Medium-term price momentum. Underlying universe rank 51; rank 1 is best.
Growth82/100Revenue and earnings growth. Underlying universe rank 19; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework41/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 48.9x Price divided by trailing earnings.
- Price / sales
- 7.5x Market value relative to trailing revenue.
- EV / EBITDA
- 27.0x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 1.6% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 63.1% Gross profit retained from each unit of revenue.
- Operating margin
- 22.7% Operating profit retained from revenue.
- Free-cash-flow margin
- 12.5% Free cash flow generated from revenue.
- Return on invested capital
- 13.3% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 20.5% Latest one-year revenue growth.
- EPS growth
- 28.0% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 198.0% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 7/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- -6.1% Net share repurchases relative to market value.
- Shareholder yield
- -6.1% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.3x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment64/100
Weighted news tone is positive across 29 relevant articles.
7 positive · 21 neutral · 1 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-3.5%Distance below the 52-week high.
13-week volatility4.2%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher17 of 269 weeks finished lower.
Best week+14.6%Week of 13 Feb.
Worst week-5.2%Week of 13 Mar.
Latest week-0.1%Week of 7 Aug.
Shape of recent returns
Strong gains10
Modest gains7
Flat weeks0
Modest losses7
Sharp losses2
Recent vol4.2%13-week weekly-return volatility.
Base vol4.6%52-week weekly-return volatility.
Up/down split20/13Count of positive and negative weeks in the 52-week window.
Average skew4.9% / -2.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Healthcare
4-week rank38 / 100
Group average1.2%
Trend breadth83.0%
Trend83.0%active weekly trend signals
MD85.0%positive activity pressure
RS73.0%positive relative leadership
Four-week leaders
IndustryIN Medical Care Facilities
4-week rank9 / 21
Group average2.1%
Trend breadth85.7%
Trend85.7%active weekly trend signals
MD76.2%positive activity pressure
RS61.9%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape52/100
Trend, activity pressure, participation, and risk combine to a 52/100 tape read.
Indicator analysis36/100Latest 12-week confirmation: trend 5/12, activity pressure 6/12, relative leadership 0/12.
Activity pressure 0.80; 17 reversal markers Next-Week ExpectancyPositive 65.89%Next-week expectancy is positive with a 65.89% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 91; Small Cap Core rank 93 SVQF41/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 930.5 of 1576 Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment64/100Weighted news tone is positive across 29 relevant articles.
Park Medi World Consolidated June 2026 Net Sales at Rs 475.71 crore, up 19.39% Y-o-Y Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 292.2 INR | -0.1% | 231.0 INR | 221.5 INR | 0.31 | - | 4.5M | On |
| 31 Jul 2026 | 292.6 INR | 4.4% | 226.2 INR | 219.3 INR | 0.67 | - | 3.4M | On |
| 24 Jul 2026 | 280.2 INR | 2.3% | 221.5 INR | 217.0 INR | 1.01 | - | 3.5M | On |
| 17 Jul 2026 | 274.0 INR | -4.2% | 217.0 INR | 215.0 INR | 1.34 | - | 8.0M | On |
| 10 Jul 2026 | 286.1 INR | -3.0% | 213.0 INR | 213.0 INR | 1.58 | - | 3.3M | On |
| 3 Jul 2026 | 294.8 INR | 3.3% | - | 210.5 INR | 1.19 | - | 1.7M | Off |
| 26 Jun 2026 | 285.5 INR | 2.8% | - | 207.5 INR | - | - | 0 | Off |
| 19 Jun 2026 | 277.6 INR | 1.1% | - | 204.6 INR | - | - | 1.7M | Off |
| 12 Jun 2026 | 274.6 INR | -2.5% | - | 201.8 INR | - | - | 890.4K | Off |
| 5 Jun 2026 | 281.8 INR | -2.4% | - | 198.9 INR | - | - | 569.9K | Off |
| 29 May 2026 | 288.5 INR | 11.3% | - | 195.4 INR | - | - | 5.7M | Off |
| 22 May 2026 | 259.2 INR | 6.0% | - | 191.4 INR | - | - | 3.0M | Off |
| 15 May 2026 | 244.5 INR | -2.1% | - | 188.3 INR | - | - | 8.7M | Off |
| 8 May 2026 | 249.8 INR | 8.3% | - | 185.6 INR | - | - | 2.8M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.